835-31-4

835-31-4结构式
835-31-4结构式
  • 常用中文名:萘甲唑啉
  • 常用英文名:naphazoline
  • CAS号:835-31-4
  • 分子式:C14H14N2
  • 分子量:210.274
  • 相关类别: 原料药 神经系统用药 拟胆碱药
  • 发布时间:2018-05-20 08:00:00
  • 更新时间:2024-01-02 18:15:43
  • 萘唑啉(萘唑啉)是一种有效的α-肾上腺素能受体激动剂。萘甲唑啉可降低血管通透性,促进血管收缩。萘唑啉可降低炎症因子(TNF-α、IL-1β和IL-6)、细胞因子(IFN-γ和IL-4)、IgE、GMCSF和NGF的水平萘甲唑啉可用于非细菌性结膜炎研究[1][2]。

化源商城直购

中文名 萘甲唑林
英文名 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
中文别名 2-(1-萘甲基)-4,5-二氢-1H-咪唑
萘达帕汀
2-(1-萘甲)咪唑啉鹽酸鹽
萘甲唑啉
英文别名 naphazoline
Sanorin
Clearine
Naphthizine
2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole
Clera
EINECS 212-641-5
MFCD00012554
Naphcon
Coldan
Antan
Nafazolina
1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-
描述 萘唑啉(萘唑啉)是一种有效的α-肾上腺素能受体激动剂。萘甲唑啉可降低血管通透性,促进血管收缩。萘唑啉可降低炎症因子(TNF-α、IL-1β和IL-6)、细胞因子(IFN-γ和IL-4)、IgE、GMCSF和NGF的水平萘甲唑啉可用于非细菌性结膜炎研究[1][2]。
相关类别
靶点

TNF-α

IL-1β

IL-6

IL-4

体内研究 萘甲唑啉(0.2 mg/kg,10µl/眼;IP,一次)降低组胺或抗原诱导的小鼠结膜血管通透性,并通过对炎症、NGF和VEGF的影响降低小鼠结膜炎[1]。动物模型:雌性野生型BALB/c小鼠(4-5周,18±2 g,n=8/组,使用组胺或抗原(卵清蛋白)建立过敏性结膜炎小鼠模型)[1]剂量:0.2 mg/mL,10µl/眼给药:腹腔注射(IP),一次结果:显著抑制组胺或抗原诱导的结膜血管通透性高的小鼠结膜色素渗漏。降低炎症反应和IL-1β、IL-6、IFN-γ和IL-4的水平。降低抗原诱导的结膜血管通透性高的小鼠中IgE、GMCSF、NGF和VEGF的水平。
参考文献

[1]. Quan L, et, al. Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. Mol Med Rep. 2016 Apr;13(4):3319-25.

[2]. Yamaguchi I, et, al. Central and peripheral adrenergic mechanisms regulating gastric secretion in the rat. J Pharmacol Exp Ther. 1977 Oct;203(1):125-31.

密度 1.2±0.1 g/cm3
沸点 440.5±24.0 °C at 760 mmHg
熔点 254ºC
分子式 C14H14N2
分子量 210.274
闪点 220.2±22.9 °C
精确质量 210.115692
PSA 24.39000
LogP 3.88
蒸汽压 0.0±1.0 mmHg at 25°C
折射率 1.640
储存条件 2-8°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ4200000
CHEMICAL NAME :
2-Imidazoline, 2-(1-naphthylmethyl)-
CAS REGISTRY NUMBER :
835-31-4
BEILSTEIN REFERENCE NO. :
0151864
LAST UPDATED :
199612
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C14-H14-N2
MOLECULAR WEIGHT :
210.30
WISWESSER LINE NOTATION :
L66J B1- BT5M CN BUTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
385 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 9,280,1950
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
270 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 29,729,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
62 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 29,729,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
514 mg/kg
TOXIC EFFECTS :
Behavioral - tremor Behavioral - convulsions or effect on seizure threshold
REFERENCE :
RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 37,198,1974
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
170 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 9,280,1950
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
950 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 9,280,1950
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
800 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FEPRA7 Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda, MD) V.1-46, 1942-87. Volume(issue)/page/year: 9,280,1950
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 192,141,1939

危害码 (欧洲) T: Toxic;
风险声明 (欧洲) R25
安全声明 (欧洲) 45
危险品运输编码 UN 2811 6.1/PG 2
WGK德国 3
RTECS号 NJ4375000
海关编码 2934999090

~%

835-31-4结构式

835-31-4

文献:DE687196 , ; DRP/DRBP Org.Chem. Przemysl Chemiczny, , vol. 32, p. 463 Chem.Abstr., , p. 11627 CH221216 , ; US2441867 , ;

~%

835-31-4结构式

835-31-4

文献:Monatshefte fuer Chemie, , vol. 80, p. 815,818

~%

835-31-4结构式

835-31-4

文献:US2813862 , ;

~%

835-31-4结构式

835-31-4

文献:Journal of the Chemical Society, , p. 497,500 US2505247 , ; DE842063 , ; DRP/DRBP Org.Chem.

~%

835-31-4结构式

835-31-4

文献:Journal of the Chemical Society, , p. 497,500 US2505247 , ; DE842063 , ; DRP/DRBP Org.Chem.

~%

835-31-4结构式

835-31-4

文献:US2813862 , ;
海关编码 2934999090
中文概述 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%